World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
119
Citations
51906
World Ranking
345
National Ranking
218

Andrew B. Ward publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrew B. Ward sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 442 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andrew B. Ward D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew B. Ward sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 119 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Antibody

Andrew B. Ward mostly deals with Virology, Epitope, Antibody, Glycan and Protein structure. His Virology study integrates concerns from other disciplines, such as HIV vaccine, Immunogen, Recombinant DNA and Antigen. His work in the fields of Gp41 overlaps with other areas such as Trimer.

The concepts of his Antibody study are interwoven with issues in Virus, Conserved sequence and Germline. He interconnects Glycosylation and Neutralizing antibody in the investigation of issues within Glycan. His work carried out in the field of Protein structure brings together such families of science as Viral entry, Protein subunit, Binding site and Cell biology.

His most cited work include:

  • Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. (1528 citations)
  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 (694 citations)
  • Crystal structure of a soluble cleaved HIV-1 envelope trimer. (671 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Virology, Antibody, Epitope, Glycoprotein and Trimer. He has included themes like Monoclonal antibody and Antigen in his Virology study. His studies in Antibody integrate themes in fields like HIV vaccine, Ebolavirus, Immune system and Vaccination.

The Epitope study combines topics in areas such as Immunogen, Recombinant DNA and Glycan. His study in Glycan is interdisciplinary in nature, drawing from both Glycosylation, Peptide sequence, Cell biology, Protein structure and Binding site. His Glycoprotein research is multidisciplinary, incorporating perspectives in Antigenicity, Immunogenicity, Hiv 1 envelope, Computational biology and Viral protein.

He most often published in these fields:

  • Virology (79.07%)
  • Antibody (61.89%)
  • Epitope (53.30%)

What were the highlights of his more recent work (between 2019-2021)?

  • Virology (79.07%)
  • Antibody (61.89%)
  • Epitope (53.30%)

In recent papers he was focusing on the following fields of study:

Virology, Antibody, Epitope, Glycoprotein and Neutralization are his primary areas of study. Andrew B. Ward mostly deals with Neutralizing antibody in his studies of Virology. His Antibody research incorporates elements of Virus, Immunity and Severe acute respiratory syndrome coronavirus 2.

His Epitope study incorporates themes from Influenza vaccine, Immunogenicity, Influenza A virus, Glycan and Polyclonal antibodies. His Glycan research integrates issues from Glycosylation, Computational biology and Gp41. Borrowing concepts from Trimer, Andrew B. Ward weaves in ideas under Glycoprotein.

Between 2019 and 2021, his most popular works were:

  • Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. (463 citations)
  • SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. (152 citations)
  • Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. (100 citations)

Best Publications

  • Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.

    Philip J. M. Brouwer;Tom G. Caniels;Karlijn van der Straten;Jonne L. Snitselaar

  • SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.

    Thomas Mandel Clausen;Thomas Mandel Clausen;Thomas Mandel Clausen;Daniel R. Sandoval;Charlotte B. Spliid;Charlotte B. Spliid;Charlotte B. Spliid;Jessica Pihl;Jessica Pihl;Jessica Pihl

  • Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

    Jesper Pallesen;Nianshuang Wang;Kizzmekia S. Corbett;Daniel Wrapp

  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman

  • A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

    Rogier W. Sanders;Rogier W. Sanders;Ronald Derking;Albert Cupo;Jean-Philippe Julien

  • Crystal structure of a soluble cleaved HIV-1 envelope trimer.

    Jean-Philippe Julien;Jean-Philippe Julien;Albert Cupo;Devin Sok;Devin Sok;Robyn L. Stanfield;Robyn L. Stanfield

  • Highly Conserved Protective Epitopes on Influenza B Viruses

    Cyrille Dreyfus;Nick S. Laursen;Ted Kwaks;David Zuijdgeest

  • Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors.

    Robert N. Kirchdoerfer;Andrew B. Ward

  • Rational HIV immunogen design to target specific germline B cell receptors

    Joseph Jardine;Jean Philippe Julien;Jean Philippe Julien;Sergey Menis;Takayuki Ota

  • A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

    Robert Pejchal;Katie J. Doores;Katie J. Doores;Laura M. Walker;Reza Khayat

  • Pre-fusion structure of a human coronavirus spike protein

    Robert N. Kirchdoerfer;Christopher A. Cottrell;Nianshuang Wang;Jesper Pallesen

  • Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

    Dmitry Lyumkis;Jean-Philippe Julien;Natalia de Val;Albert Cupo

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.

    Antonietta Impagliazzo;Fin Milder;Harmjan Kuipers;Michelle V. Wagner

  • Cross-neutralization of influenza A viruses mediated by a single antibody loop.

    Damian C. Ekiert;Arun K. Kashyap;John Steel;John Steel;Adam Rubrum

  • HIV-1 neutralizing antibodies induced by native-like envelope trimers

    Rogier W. Sanders;Rogier W. Sanders;Marit J. Van Gils;Ronald Derking;Devin Sok;Devin Sok

  • Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.

    Robert N. Kirchdoerfer;Nianshuang Wang;Jesper Pallesen;Daniel Wrapp;Daniel Wrapp

  • Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface

    Jinghe Huang;Byong H. Kang;Marie Pancera;Jeong Hyun Lee

  • Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer.

    Jeong Hyun Lee;Gabriel Ozorowski;Andrew B. Ward

  • Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers

    Emilia Falkowska;Khoa M. Le;Khoa M. Le;Alejandra Ramos;Alejandra Ramos;Katie J. Doores;Katie J. Doores;Katie J. Doores

  • A Blueprint for HIV Vaccine Discovery

    Dennis R. Burton;Rafi Ahmed;Rafi Ahmed;Dan H. Barouch;Dan H. Barouch;Dan H. Barouch;Salvatore T. Butera

Frequent Co-Authors

Ian A. Wilson
Ian A. Wilson Scripps Research Institute
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
John P. Moore
John P. Moore Cornell University
Hannah L. Turner
Hannah L. Turner Scripps Research Institute
Max Crispin
Max Crispin University of Southampton
Devin Sok
Devin Sok Scripps Research Institute
Shane Crotty
Shane Crotty La Jolla Institute For Allergy & Immunology
Per Johan Klasse
Per Johan Klasse Cornell University
William R. Schief
William R. Schief Scripps Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare and nursing pathways can open diverse career opportunities. Many students transitioning into healthcare consider programs like accelerated np programs, which provide a swift route to becoming a Nurse Practitioner with specialized clinical skills and advanced practice knowledge.

Non-nurses looking to enter the field might find online adn programs for non nurses particularly appealing. These programs are designed to build foundational nursing competencies while accommodating students without prior healthcare experience.

Students seeking a faster entry into nursing may also explore accelerated nursing programs, which streamline the Bachelor of Science in Nursing curriculum without compromising quality. Similarly, individuals aiming for practical nursing roles can consider the best easiest lpn programs to get into to quickly gain licensure and begin hands-on patient care.

Understanding these pathways is essential for building a rewarding career that intersects with immunology, as these nursing roles often collaborate closely with immunologists in clinical settings or public health initiatives.

Best Scientists Citing Andrew B. Ward

Trending Scientists

Recently Published Articles